Shengtai Pharmaceutical Inc., (OTC BB: SGTI) is China’s leading manufacturer and supplier of pharmaceutical grade glucose for medicinal purposes. In addition to their pharmaceutical glucose series of products, they also produce other medicinal product lines as well such as industrial glucose, syrup, starch, avermectins, dextrin, maltose and maltitol, which are used for food, beverage and industrial production. Based in China, Shengtai has an international client-base. For further information, visit the company website at: www.shengtaipharmaceutical.com.
- 18 years ago
QualityStocks
Shengtai Pharmaceutical Inc., (OTC BB: SGTI)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Completes 2026 Field Exploration Program at Cameron Project
Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising. Powermax Minerals…
-
SS Innovations International Inc. (NASDAQ: SSII) Expands Robotic Cardiac Surgery Footprint with New Program at HCG Hospital in Ahmedabad
The program began with a robotic left internal mammary artery (“LIMA”) take-down performed by Dr.…
-
Quantum BioPharma Ltd. (NASDAQ: QNTM) Receives FDA Green Light to Move Lucid-MS into Phase 2 Testing
The FDA IND approval marks a pivotal step for the company's lead compound, known as…